228 related articles for article (PubMed ID: 16511381)
1. Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.
Bowlware KL; McCracken GH; Lozano-Hernandez J; Ghaffar F
Pediatr Infect Dis J; 2006 Mar; 25(3):208-10. PubMed ID: 16511381
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
Arguedas A; Dagan R; Leibovitz E; Hoberman A; Pichichero M; Paris M
Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
[TBL] [Abstract][Full Text] [Related]
3. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
Garbutt J; Rosenbloom I; Wu J; Storch GA
Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
[TBL] [Abstract][Full Text] [Related]
4. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
Block SL; Cifaldi M; Gu Y; Paris MM
Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
8. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
[TBL] [Abstract][Full Text] [Related]
9. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Sakata H
Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154
[No Abstract] [Full Text] [Related]
11. Seasonal distribution of otitis media pathogens among Costa Rican children.
Guevara S; Soley C; Arguedas A; Porat N; Dagan R
Pediatr Infect Dis J; 2008 Jan; 27(1):12-6. PubMed ID: 18162931
[TBL] [Abstract][Full Text] [Related]
12. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Dagan R; Abramson O; Leibovitz E; Lang R; Goshen S; Greenberg D; Yagupsky P; Leiberman A; Fliss DM
Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545
[TBL] [Abstract][Full Text] [Related]
13. Use of oral cephalosporins in the treatment of acute otitis media in children.
Brook I
Int J Antimicrob Agents; 2004 Jul; 24(1):18-23. PubMed ID: 15225855
[TBL] [Abstract][Full Text] [Related]
14. The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory tract infections.
Kaplan SL
Semin Respir Infect; 1995 Mar; 10(1):31-6. PubMed ID: 7761712
[TBL] [Abstract][Full Text] [Related]
15. Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media.
Toltzis P; Dul M; Blumer J
Pediatr Infect Dis J; 2007 Jul; 26(7):647-9. PubMed ID: 17596812
[TBL] [Abstract][Full Text] [Related]
16. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections.
Furuno JP; Metlay JP; Harnett JP; Wilson J; Langenberg P; McGregor JC; Zhu J; Perencevich EN
Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):1-9. PubMed ID: 16136615
[TBL] [Abstract][Full Text] [Related]
17. [Mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
Yokoyama M
Jpn J Antibiot; 2001 May; 54 Suppl B():88-90. PubMed ID: 12638152
[No Abstract] [Full Text] [Related]
18. Management of acute otitis media caused by resistant pneumococci in infants.
Roger G; Carles P; Pangon B; Thien HV; Polonovski JM; Begue P; Garabedian EN
Pediatr Infect Dis J; 1998 Jul; 17(7):631-8. PubMed ID: 9686731
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
20. Cefdinir: an expanded-spectrum oral cephalosporin.
Guay DR
Ann Pharmacother; 2000 Dec; 34(12):1469-77. PubMed ID: 11144705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
